These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 27855133)

  • 21. The impact of genetic polymorphisms and patient characteristics on warfarin dose requirements: a cross-sectional study in Iran.
    Namazi S; Azarpira N; Hendijani F; Khorshid MB; Vessal G; Mehdipour AR
    Clin Ther; 2010 Jun; 32(6):1050-60. PubMed ID: 20637959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of coagulation factor, vitamin K epoxide reductase complex subunit 1, and cytochrome P450 2C9 gene polymorphisms on warfarin dose requirements.
    Aquilante CL; Langaee TY; Lopez LM; Yarandi HN; Tromberg JS; Mohuczy D; Gaston KL; Waddell CD; Chirico MJ; Johnson JA
    Clin Pharmacol Ther; 2006 Apr; 79(4):291-302. PubMed ID: 16580898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of genetic polymorphisms of CYP2C9 and VKORC1 - implications for warfarin management and outcome in Croatian patients with acute stroke.
    Supe S; Božina N; Matijević V; Bazina A; Mišmaš A; Ljevak J; Alvir D; Habek M; Poljaković Z
    J Neurol Sci; 2014 Aug; 343(1-2):30-5. PubMed ID: 24974237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the predictive performance of Bayesian dosing for warfarin in Chinese patients.
    Dong J; Shi GH; Lu M; Huang S; Liu YH; Yao JC; Li WY; Li LX
    Pharmacogenomics; 2019 Feb; 20(3):167-177. PubMed ID: 30777785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a pharmacogenetic-based warfarin dosing algorithm and its performance in Brazilian patients: highlighting the importance of population-specific calibration.
    Santos PC; Marcatto LR; Duarte NE; Gadi Soares RA; Cassaro Strunz CM; Scanavacca M; Krieger JE; Pereira AC
    Pharmacogenomics; 2015 Jul; 16(8):865-76. PubMed ID: 26050796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Linkage disequilibrium between the CYP2C19*2,*17 and CYP2C9*1 alleles and impact of VKORC1, CYP2C9, CYP2C19 gene polymorphisms and gene-gene interactions on warfarin therapy.
    Khalighi K; Cheng G; Mirabbasi S; Khalighi B; Wu Y; Fan W
    J Thromb Thrombolysis; 2017 Jan; 43(1):124-129. PubMed ID: 27743182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genotypes of vitamin K epoxide reductase, gamma-glutamyl carboxylase, and cytochrome P450 2C9 as determinants of daily warfarin dose in Japanese patients.
    Kimura R; Miyashita K; Kokubo Y; Akaiwa Y; Otsubo R; Nagatsuka K; Otsuki T; Okayama A; Minematsu K; Naritomi H; Honda S; Tomoike H; Miyata T
    Thromb Res; 2007; 120(2):181-6. PubMed ID: 17049586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of optimal warfarin maintenance dose using advanced artificial neural networks.
    Grossi E; Podda GM; Pugliano M; Gabba S; Verri A; Carpani G; Buscema M; Casazza G; Cattaneo M
    Pharmacogenomics; 2014 Jan; 15(1):29-37. PubMed ID: 24329188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Construction of warfarin population pharmacokinetics and pharmacodynamics model in Han population based on Bayesian method.
    Xia X; Cai X; Chen J; Jiang S; Zhang J
    Sci Rep; 2024 Jun; 14(1):14846. PubMed ID: 38937509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Bayesian dose-individualization method for warfarin.
    Wright DF; Duffull SB
    Clin Pharmacokinet; 2013 Jan; 52(1):59-68. PubMed ID: 23329393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a bayesian forecasting method for warfarin dose individualization.
    Wright DF; Duffull SB
    Pharm Res; 2011 May; 28(5):1100-11. PubMed ID: 21301936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the prediction performance of different warfarin dosing algorithms based on Chinese patients.
    Xie C; Xue L; Zhang Y; Zhu J; Zhou L; Hang Y; Ding X; Jiang B; Miao L
    Pharmacogenomics; 2020 Jan; 21(1):23-32. PubMed ID: 31849278
    [No Abstract]   [Full Text] [Related]  

  • 33. A Bayesian Estimation Framework for Pharmacogenomics Driven Warfarin Dosing: A Comparative Study.
    Öztaner SM; Temizel TT; Erdem SR; Özer M
    IEEE J Biomed Health Inform; 2015 Sep; 19(5):1724-33. PubMed ID: 25020183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of gene modules associated with warfarin dosage by a genome-wide DNA methylation study.
    Luo Z; Liu R; Sun B; Zhou X; Liu Z; Zhou H; Xu H; Li X; Zhang W
    Pharmazie; 2018 May; 73(5):288-293. PubMed ID: 29724296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Automated warfarin dose prediction for Asian, American, and Caucasian populations using a deep neural network.
    Jahmunah V; Chen S; Oh SL; Acharya UR; Chowbay B
    Comput Biol Med; 2023 Feb; 153():106548. PubMed ID: 36652867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of multivariate linear regression and a machine learning algorithm developed for prediction of precision warfarin dosing in a Korean population.
    Nguyen VL; Nguyen HD; Cho YS; Kim HS; Han IY; Kim DK; Ahn S; Shin JG
    J Thromb Haemost; 2021 Jul; 19(7):1676-1686. PubMed ID: 33774911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Warfarin Dosing Algorithms Underpredict Dose Requirements in Patients Requiring ≥7 mg Daily: A Systematic Review and Meta-analysis.
    Saffian SM; Duffull SB; Wright D
    Clin Pharmacol Ther; 2017 Aug; 102(2):297-304. PubMed ID: 28160278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. External Evaluation of a Bayesian Warfarin Dose Optimization Based on a Kinetic-Pharmacodynamic Model.
    Aoyama T; Hirai T; Tsuji Y; Miyamoto A; Itoh T; Iwamoto T; Matsumoto Y
    Biol Pharm Bull; 2022; 45(1):136-142. PubMed ID: 34980775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bayesian pharmacokinetic/pharmacodynamic forecasting of prothrombin response to warfarin therapy: preliminary evaluation.
    Svec JM; Coleman RW; Mungall DR; Ludden TM
    Ther Drug Monit; 1985; 7(2):174-80. PubMed ID: 4024210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of the plasma levels of proteins C and S on the prediction of warfarin maintenance dose requirements.
    Lubetsky A; Seligsohn U; Ezra D; Halkin H
    Clin Pharmacol Ther; 1992 Jul; 52(1):42-9. PubMed ID: 1385564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.